Due to this fact, a reduction in omentin levels is associated with an increase in metabolic risk factors, suggesting its use as a negative biomarker for obesity (De Souza Batista et al., 2007). This evidence concerns the gene ITLN1 and obesity due to melanocortin 4 receptor deficiency.